Trial reportBMC urology2026
Prospective randomized analysis of operating time and safety of laparoscopic pyeloplasty with or without TriSect rapide® in adult patients with ureteropelvic junction obstruction.
Trial report in BMC urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMultifunctional instruments like the TriSect rapide
methodsIn this prospective, randomized trial, 22 patients undergoing laparoscopic pyeloplasty for ureteropelvic junction (UPJ) obstruction were allocated to receive surgery using either the TriSect rapide
resultsThe median follow-up was 46 weeks. No significant differences were observed between groups regarding demographic factors, renal function, or intra- and perioperative complications. The intervention group demonstrated a significantly shorter preparation time (83 ± 29.8 vs. 122 ± 32.5 min, p = 0.009), resulting in a reduced total operative time (170 ± 32.0 vs. 211 ± 41.6 min, p = 0.017) and shorter anesthesia duration (221 ± 41.0 vs. 259 ± 41.5 min, p = 0.046). Reconstruction time did not differ significantly (87 ± 14.6 vs. 89 ± 11.1 min, p = 0.639). Complication rates according to the Clavien-Dindo classification were comparable between groups (p = 0.935). Quality-of-life analysis using the RAND SF-36 questionnaire revealed no between-group differences at either time point, although both groups showed significant postoperative improvement compared with baseline (p < 0.001).
conclusionThe use of the TriSect rapide® multifunctional device in laparoscopic pyeloplasty is safe and effective for preparation, dissection and incision. Its application significantly reduces preparation time by approximately 32% without increasing perioperative complications or affecting postoperative quality of life. These findings support the clinical value of multifunctional instruments in improving procedural efficiency while maintaining safety in reconstructive urologic surgery.
trial registrationIn compliance with international guidelines for clinical trial transparency, this study was retrospectively registered in the ISRCTN registry (registration number: ISRCTN15328718) on August 7, 2025.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.